4 completed. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
Follow alpha-Mannosidosis: new trials by email Literature Review of alpha-Mannosidosis trials Research Report on alpha-Mannosidosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Long-term Efficacy of Treatment With Lamazym Lamazym - Alpha-Mannosidosis | Phase 3 | Completed | Zymenex A/S | 18 | 2015-02-01 | 2020-11-20 |
| Lamazym Aftercare Study FR Designed to Provide Treatment for French Patients Lamazym - Alpha-Mannosidosis | Phase 3 | Completed | Chiesi Farmaceutici S.p.A. | 13 | 2013-08-01 | 2023-07-28 |
| Lamazym Aftercare Study Lamazym - Alpha-Mannosidosis | Phase 3 | Completed | Chiesi Farmaceutici S.p.A. | 8 | 2013-06-01 | 2023-07-28 |
| A Placebo-Controlled Phase 3 Trial of Repeated Lamazym Treatment of Subjects With Alpha-Mannosidosis Lamazym, Placebo - Alpha-Mannosidosis | Phase 3 | Completed | Zymenex A/S | 25 | 2012-08-01 | 2020-08-03 |
Carbohydrate Metabolism, Inborn Errors (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Genetic Diseases, Inborn (4) · Lysosomal Storage Diseases (4) · Mannosidase Deficiency Diseases (4) · Metabolic Diseases (4) · Metabolism, Inborn Errors (4) · Nutritional and Metabolic Diseases (4)
Chiesi Farmaceutici S.p.A. (2) · Zymenex A/S (2)
Denmark (3) · France (2) · Germany (1) · Poland (1) · United Kingdom (1)
Allan M Lund, MD (2) · Jens Fogh (1) · Jens M Fogh, DVM (1)